← Leaderboards
Erik Sulman
University Of Tx Md Anderson Can Ctr
$6,610,770
Attributed
$9,681,596
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2014–25$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,681,596 · 5
By mechanism
R01$6,088,192 · 3
T32$2,949,736 · 1
K12$643,668 · 1
Top collaborators
- Krishna Pl Bhat8 shared
- Roel Gw Verhaak4 shared
- Jeffrey S Weber1 shared
Most similar at University Of Tx Md Anderson Can Ctr
Same institution · by research overlap
- Jian Hu$8,609,311
- Vahid Afshar-Kharghan$3,543,397
- Anil K Sood$29,572,737
- Krishna Pl Bhat$3,427,143
- Rugang Zhang$23,913,209
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsAdultBrain NeoplasmsExcisionRecurrenceGliomaUnited StatesGlioblastomaNeoplastic CellTumorTumor-DerivedGrowthHeterogeneitySamplingTumor ProgressionTherapy ResistantTreatment ResponseEvolutionBiopsyBiological MarkersClinical TrialsChemoradiationGrantTumor Biology
Grant awards (16)
Exploiting cell fate transition to overcome radiation resistance in glioblastoma$676,623
R01 · FY2025 · CA · contact PI
Medical Scientist Research Service Award$1,498,398
T32 · FY2024 · GM · contact PI
Exploiting cell fate transition to overcome radiation resistance in glioblastoma$652,198
R01 · FY2024 · CA · contact PI
K12 Training for Clinical and Translational Oncology Researchers$590,208
K12 · FY2024 · CA · contact PI
Medical Scientist Research Service Award$1,451,338
T32 · FY2023 · GM · contact PI
Exploiting cell fate transition to overcome radiation resistance in glioblastoma$709,593
R01 · FY2023 · CA · contact PI
Bidirectional interaction of platelets and tumor cells in patients with glioblastoma$560,515
R01 · FY2023 · CA · contact PI
K12 Training for Clinical and Translational Oncology Researchers$53,460
K12 · FY2023 · CA
Bidirectional interaction of platelets and tumor cells in patients with glioblastoma$560,514
R01 · FY2022 · CA · contact PI
Bidirectional interaction of platelets and tumor cells in patients with glioblastoma$571,954
R01 · FY2021 · CA · contact PI
Bidirectional interaction of platelets and tumor cells in patients with glioblastoma$490,666
R01 · FY2020 · CA · contact PI
Bidirectional interaction of platelets and tumor cells in patients with glioblastoma$508,041
R01 · FY2019 · CA · contact PI
(PQ #4) Single cell barcoding for studies of study clonal evolution in glioblastoma$362,088
R01 · FY2017 · CA
(PQ #4) Single cell barcoding for studies of study clonal evolution in glioblastoma$332,000
R01 · FY2016 · CA
(PQ #4) Single cell barcoding for studies of study clonal evolution in glioblasto$332,000
R01 · FY2015 · CA
(PQ #4) Single cell barcoding for studies of study clonal evolution in glioblasto$332,000
R01 · FY2014 · CA